“Why is everyone saying waiting on Brazil? While
Post# of 148155
There is no trial in PI, just Compassionate Special Permit (CSP) with no requirement to report data back to the company and if they did the data would be considered anecdotal as it is not a randomized controlled trial - so, no influence on getting an EUA or approval. The hope was that CSPs would drive revenue. So far we don’t have any word of data or revenue....
Brazil has two formal RC trials, which in theory will be recognized by the US and other countries for EUAs and approval - a more definite target for a catalyst.
Read More: https://investorshangout.com/post/newpost/605...z6wHZm9Osx